Tag: drug pricing

Prescription Drug Pricing Tracker

Introduction to Prescription Drug Pricing Tracker The McDermottPlus Prescription Drug Pricing Tracker provides a comprehensive list of major bills, laws, and agency rules and regulations that impact the prescription drug pricing a...

Summary of Senate Finance Prescription Drug Package

Senate Finance Committee posts description of the Chairman’s mark of its legislation addressing prescription drug pricing. Today, July 23, 2019, the Senate Finance Committee posted a description of the Chairman’s mark of its legislation addres...

Administration Withdraws Rebate Overhaul Proposal

The Administration has announced it is no longer pursuing its drug pricing proposal that would have required pharmacy benefit managers to pass rebates directly on to the patient. The Administration has announced it is no longer pursuing its drug p...

Judge Axes Price Disclosure Rule for Drug Ads

The Trump administration cannot force drug manufacturers to disclose prices in their pharmaceutical ads to consumers, a federal judge ruled Monday....

Prescription Drug Legislation Considered

House E&C Health Subcommittee holds legislative hearing to examine seven bills related to lowering the cost of prescription drugs. The House Energy and Commerce Health Subcommittee held a legislative hearing examining seven bills related to l...

Accelerated Drug Approval for Prescription Therapies (ADAPT) Act

On March 6, 2019, Senator Mike Braun (R-IN) introduced the Accelerated Drug Approval for Prescription Therapies (ADAPT) Act (S. 658), which would create an expedited drug approval process at FDA specifically for drugs that are currently approved for ...

Drug Price Transparency (DPT) Act

On March 6, 2019, Senator Mike Braun (R-IN) introduced the Drug Price Transparency (DPT) Act (S. 657), which would extend the idea of the HHS OIG PBM rebate rule to the commercial insurance market and prohibit PBMs from receiving any rebates or reduc...